Facebooktwitterlinkedin

Asepsis begins production and marketing of its specialty general anesthetic portfolio

Asepsis announces the launch of Caspofungin Acetate for Injection in India.  This is Asepsis’s second product launch in India.  Asepsis plans to launch several more products in India in 2014.  Caspofungin is one of the first in the advanced anti-fungal drug class called echinocandis. These antifungals are indicated for the treatment of serious and/or resistant infections. It is often used in patients who cannot use or do not respond to other antifungal medications.

  • Share Us
  • Facebooktwitterlinkedin

    USA

    Asepsis Pharmaceuticals Inc.
    1584 Independence Blvd.
    Sarasota, FL 34234
    United States
    Tel: +1 888-608-8884
    Fax: +1 888-608-8885
    info@asepsispharma.com

    Mexico

    Asepsis Pharma SA de CV
    La Polar #6 DEPTO1 Colonial Del.
    Gustavo A Madero C.P. 07800
    Mexico D.F.
    Tel: +52 (55) 5750-3516
    Fax: +52 (55) 2789-5706
    info@asepsispharma.com

    India

    Asepsis Pharmaceuticals Pvt. Ltd.
    226, Patel Center, Sainath
    Road Malad West
    Mumbai
    Tel: +91 22 2844 2942
    Fax: +91 22 6645 9822
    info@asepsispharma.com

    China

    Asepsis Pharmaceuticals Ltd.
    12 F Merrit Industrial
    Center Kowloon,
    Hong Kong
    Tel: +852 9018 2393
    Fax: +852 3010 1873
    info@asepsispharma.com